Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease I: Ulcerative Colitis

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

Bacterial Flora of the Large Intestine

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dental amalgams and blood mercury concentrations in American adults.

Clinical chemistry and laboratory medicine·2025

Same author

Tooth decay prevention and neurodevelopmental disorder risk following childhood fluoride exposure.

BMC pediatrics·2025

Same author

Constitutional chromosomal anomalies in children, fetal alcohol syndrome, and maternal toxicant exposures: A longitudinal cohort study.

Mutation research. Genetic toxicology and environmental mutagenesis·2024

Same author

Estimated mercury vapor exposure from amalgams among American pregnant women.

Human & experimental toxicology·2024

Same author

Reductions in plasma and urine mercury concentrations following N,N'bis-(2-mercaptoethyl) isophthalamide (NBMI) therapy: a post hoc analysis of data from a randomized human clinical trial.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2023

Same author

Urine glyphosate exposure and serum sex hormone disruption within the 2013-2014 National Health and Nutrition Examination survey (NHANES).

Chemosphere·2023

Search research articles

Related Experiment Video

Updated: Jul 23, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Colon Cancer Risk Following Intestinal Clostridioides difficile Infection: A Longitudinal Cohort Study.

David A Geier¹, Mark R Geier¹

¹Research Department, Institute of Chronic Illnesses, Inc., Silver Spring, MD, USA.

Journal of Clinical Medicine Research

|July 12, 2023

Summary

Individuals with intestinal Clostridioides difficile (Cdiff) infection face a significantly higher risk of developing colon cancer. This study highlights a potential link between Cdiff and increased colon cancer incidence, warranting further investigation.

Keywords:

Clostridioides difficile Colon cancer Intestinal infection Longitudinal cohort

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Related Experiment Videos

Last Updated: Jul 23, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Area of Science:

Gastroenterology
Oncology
Microbiology

Background:

The gut microbiome's role in colon cancer etiology and progression is increasingly recognized.
This study investigates the association between intestinal Clostridioides difficile (Cdiff) infection and colon cancer incidence.

Purpose of the Study:

To compare colon cancer incidence rates between adults with and without a history of intestinal Cdiff infection.
To assess the epidemiological link between Cdiff infection and the risk of developing colon cancer.

Main Methods:

A longitudinal cohort study utilizing de-identified healthcare records from Florida Medicaid (1990-2012).
Comparison of colon cancer incidence between a Cdiff cohort (n=964) and a non-Cdiff cohort (n=292,136).
Analysis employed frequency and Cox proportional hazards models, adjusting for multiple confounding factors.

Main Results:

Colon cancer incidence increased markedly in the Cdiff cohort within 4 years of diagnosis.
The Cdiff cohort exhibited a 2.7-fold higher colon cancer incidence (3.11 per 1,000 person-years) compared to the non-Cdiff cohort (1.16 per 1,000 person-years).
Adjustments for various demographic, lifestyle, and medical history factors did not alter the observed association.

Conclusions:

This is the first epidemiological study to associate Cdiff infection with an elevated risk of colon cancer.
The findings suggest a significant relationship between Cdiff and increased colon cancer risk.
Further research is recommended to elucidate the mechanisms underlying this association.